Form 4 for CRL Charles River Laboratories
Accepted 2026-05-28 16:33:03 ET · period of report 2026-05-26 · accession 0001100682-26-000079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-28 16:33 | 2026-05-26+ | CRL | Girshick Birgit | CEO | F - Tax | $158.90 | -618 | 31.0K | -2% | -$98.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-26 | F | D | 376 | $160.30 | 31,262 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-27 | F | D | 242 | $156.73 | 31,020 | D | — | — |